Kurzfassung

Randomized, Double-Masked, Active Controlled, Crossover Phase III Equivalence Study of Bimatoprost 0.1 mg/ml eye drops, solution (re-formulated) compared to Lumigan 0.1 mg/ml eye drops solution in Subjects with Open Angle Glaucoma or Ocular Hypertension